Interleukin 10-expressing B cells inhibit tumor-infiltrating T cell function and correlate with T cell Tim-3 expression in renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Interleukin 10-expressing B cells inhibit tumor-infiltrating T cell function and correlate with T cell Tim-3 expression in renal cell carcinoma

Published:2015-12-30 Issue:6 Volume:37 Page:8209-8218
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Cai Chen,Zhang Jin,Li Minyu,Wu Zhen-Jie,Song Ken H.,Zhan Tina W.,Wang Lin-Hui,Sun Ying-Hao

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-015-4687-1.pdf

Reference38 articles.

1. Vogelzang NJ, Stadler WM. Kidney cancer. Lancet. 1998;352:1691–6.

2. Rini BI, Campbell SC, Escudier B. Renal cell carcinoma. Lancet. 2009;373:1119–32.

3. Wallen EM, Pruthi RS, Joyce GF, Wise M. Kidney cancer. J Urol. 2007;177:2006–18. discussion 2018–9.

4. Motzer RJ, Hutson TE, McCann L, Deen K, Choueiri TK. Overall survival in renal-cell carcinoma with pazopanib versus sunitinib. N Engl J Med. 2014;370:1769–70.

5. Motzer RJ, Russo P. Systemic therapy for renal cell carcinoma. J Urol. 2000;163:408–17.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The molecular landscape of T cell exhaustion in the tumor microenvironment and reinvigoration strategies;International Reviews of Immunology;2024-09-11

2. The role of CD20⁺ T cells: Insights in human peripheral blood;Cytometry Part B: Clinical Cytometry;2024-05

3. Temporal tissue dynamics from a single snapshot;2024-04-26

4. Metabolically activated and highly polyfunctional intratumoral VISTA+ regulatory B cells are associated with tumor recurrence in early stage NSCLC.;2024-01-30

5. TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors;Cancer Immunology, Immunotherapy;2023-08-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3